BIOPLUS-INTERPHEX KOREA 2026

How it compares

BIX belongs on the shortlist when the commercial objective depends on Korean biopharma: finding a local process supplier, discussing a CDMO project, or meeting companies looking for research, investment and licensing partners. Manufacturing and business development sit close together here, with Korean clusters and public research bodies alongside global service providers.

INTERPHEX in New York offers a larger supplier field for North American pharmaceutical operations. Its 2026 show featured more than 600 exhibiting brands across development, technology transfer, compliance, processing and distribution. A plant engineering team comparing production equipment across many vendors has a stronger reason to make that trip. BIX is a more concentrated setting for understanding Korean manufacturing relationships and combining supplier conversations with partnership discussions.

INTERPHEX Week Tokyo provides another route into Asian pharmaceutical sourcing. Its six specialist exhibitions cover manufacturing and packaging, ingredients, biopharmaceuticals, drug discovery, digital transformation and CMO/CDMO services, with regenerative medicine alongside them. Tokyo is the more direct choice for Japanese supplier development or cell and tissue engineering procurement. Choose BIX when Korea is central to the market plan and the same team needs to discuss both production and commercialization.

BIX suits biotech business-development and manufacturing teams that need Korean partners across drug development, production and market expansion.

Who exhibits

The exhibitor mix connects global bioprocess suppliers with Korean manufacturing and development businesses. Merck, Cytiva and Sartorius sit alongside CDMOs such as Lonza, KBI Biopharma and AGC Biologics. ABEC brings production systems, while Agilent and Bio-Rad anchor laboratory analysis. CEVA Logistics, Envirotainer and GEODIS make cold-chain delivery a visible part of the floor. Canadian companies and Korean cluster pavilions add a second layer of research, investment and commercialization conversations.

1. 

   Agilent

2. 

   Testo

3. 

   Yokogawa Electric

4. 

   Hamilton Company

5. 

   Iqvia

6. 

   Bio-Rad

7. 

   Merck

8. 

   Waters

9. 

   bioMérieux

10. 

    Beckman Coulter Life Sciences

11. 

    Lonza

12. 

    Hangzhou Cobetter Filtration Equipment

13. 

    Ceva Logistics

14. 

    Alconox

15. 

    Almac Group

16. 

    Biointron

17. 

    Kactus

18. 

    Levitronix

19. 

    Catalent

20. 

    GEODIS

21. 

    Oetiker

22. 

    IQVIA Laboratories

23. 

    Sarstedt

24. 

    KBI Biopharma

294 companies are on the list. A HallBrief brief ranks every one against your goals and finds who to meet at each. Get a brief

BIOPLUS-INTERPHEX KOREA 2026

Canada is the Country of Honor at BIX 2026, with a delegation of around 30 biotechnology and healthcare companies. The Canada Pavilion includes drug developers, research institutions and digital health businesses, creating a wider set of potential partners for Korean companies. The program also features a brain-computer interface demonstration and discussions around Food as Medicine. Stem-cell therapies and global biopharma M&A are conference themes, placing emerging treatments and company strategy alongside the manufacturing exhibition.

• For Canadian collaborations, start with the O03 pavilion, where the Embassy of Canada brings together drug developers, research organizations and digital health companies; LithuaniaBIO's separate pavilion is at O04.
• Use BIX Partnering for licensing, investment or joint-research discussions. Visitor participation requires opting in during pre-registration, and confirmed meetings take place in The Platz on the second floor.
• Distinguish conference content from business hospitality when choosing a pass: Prime includes keynotes and featured sessions, EE includes Clubhouse and concierge service, and All-Inclusive adds the reception.